Dirloctocogene samoparvovec

萨迪可基

Report date: 2023/10/26 16:03:12

Base Information

Drug NameDirloctocogene samoparvovec

Drug Alias Name第八因子基因疗法八因子基因疗法SPK-8011RG-6357

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV-Spark200 vector

Mechanisms of ActionBlood coagulation pathway activationCoagulation factor VIII modulatorsFactor VIII gene transference

TargetsCoagulation factor VIII

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesThailand +[5]

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHemophilia A

Inactive IndicationsN/A

ATC CodeN/A